chr12-6828543-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_014262.5(P3H3):āc.103C>Gā(p.Gln35Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00184 in 1,276,360 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 10/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014262.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000900 AC: 136AN: 151190Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000438 AC: 2AN: 4562Hom.: 0 AF XY: 0.000343 AC XY: 1AN XY: 2914
GnomAD4 exome AF: 0.00197 AC: 2216AN: 1125060Hom.: 7 Cov.: 30 AF XY: 0.00191 AC XY: 1031AN XY: 540032
GnomAD4 genome AF: 0.000899 AC: 136AN: 151300Hom.: 0 Cov.: 31 AF XY: 0.000906 AC XY: 67AN XY: 73916
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 31, 2024 | The c.103C>G (p.Q35E) alteration is located in exon 1 (coding exon 1) of the P3H3 gene. This alteration results from a C to G substitution at nucleotide position 103, causing the glutamine (Q) at amino acid position 35 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at